Introduction
Breast screening entails assessing the woman’s mammary glands for any signs that might indicate cancer. There are benefits associated with breast screening, like identifying cancer in its early stages, which might increase the chances of its successful treatment. Breast cancer is a notable issue across the globe. Since there is no known cure for cancer yet, early detection is one of the best ways health practitioners have to beat cancer. There are many breast screening programs established to ensure women are screened as part of preventive care for women’s health. This essay examines the significance of breast screening programs, the target population they serve, their importance and limitations, and the role imaging plays in the process.
Breast Screening Program
Breast screening programs are organized healthcare initiatives designed to detect breast cancer at an early, often asymptomatic stage when treatment is most effective. In such organizations, specialized personnel carry out mammography procedures, among other screening techniques, on women to promote the identification of breast cancer (Murphy, 2023). There are different programs operating breast cancer screening depending on the level of technology, costs, benefits, and risks associated.
Every country operates screening programs under specific standards that health providers must follow. The primary demographic targeted by these programs is women, typically aged 40 or older, although specific age recommendations may vary from one country to another (Murphy, 2023). For instance, Australia provides breast screening freely for women above a certain age but requires those between 50 and 74 years to be tested at least every 2 years (Murphy, 2023). It differs in Canada, where women aged 40 to 79 years are screened once every two years at no charge (Murphy, 2023). The U.S. operates a national cervical and breast cancer early identification program through the CDC, which extends screening services to low-income-earning women (Murphy, 2023). Therefore, screening programs employ various screening techniques, and the age group subjected to testing differs from state to state.
Imaging in Breast Screening
Early Detection
Imaging necessitates early detection of breast cancer, especially in patients with a genetic history of the condition. Imaging helps determine whether someone is cancer-free or identify and classify the types of cancer they might possess. Mammography is highly effective in detecting breast abnormalities, including microcalcifications and tumors, often before they are palpable (Forrai et al., 2022).
Current advanced mammography determines the size of breast tumors and the extent of their spread early for treatment. According to Forrai et al. (2022), individuals need to be sufficiently educated before undergoing screening tests to prepare them psychologically for any results that may emerge. There are various ways that people can learn more about breast cancer screening, including reliable internet sources and cancer specialists who can talk to women on the topic.
Risk Assessment
Imaging can help assess a woman’s breast cancer risk based on findings such as breast density and the presence of specific markers. Many women have reported feeling relieved after taking cancer tests. Mammography tests are usually preferred for women above 40 years due to the risks involved. However, younger women can undertake the test, especially when there are suspicions that might indicate a high chance of having breast cancer.
It is essential to conduct genetic counseling for women to help them comprehend the possibility of testing positive for breast cancer. As stated by Nelson et al. (2019), some people find it better to cope with mammography results when they have been taken through counseling. Care providers concerned with breast cancer imaging need to consider not only the possibility of having cancer but also the psychological concerns arising from the entire process.
Diagnostic Confirmation
Abnormal findings on screening mammograms may lead to further diagnostic imaging, such as diagnostic mammography, ultrasound, or MRI, to confirm the presence of cancer and determine its stage. Imaging may provide an initial basis to refer a person to further testing to confirm any unusual findings. With the advancement of technologies, imaging has enabled accurate diagnoses with minimal margins of error (Zhang et al., 2023). Doctors can begin health procedures as soon as a diagnosis is made. Therefore, cancer can be identified early and treated before it matures to the symptomatic stage, which comes with some adverse effects on the patient.
Guidance for Treatment
Imaging helps guide treatment decisions, such as determining the extent of disease and the need for surgery, radiation, or chemotherapy. Imaging facilitates the monitoring of disease extent, position on the breast, and its type, allowing doctors to direct the best course of action (Kuhl, Lehman, and Bedrosian, 2020). Before surgery is conducted on a patient, imaging is employed to confirm the exact size of the cancer in the breast and to guide the surgeons on the exact place to conduct their procedure. Thus, the imaging process is essential within breast cancer screening programs, as they are used in different settings.
Reduction of Cancer Mortality Rates
Imaging has prevented many deaths over the years by making cancer detection at early stages possible. More people are getting tested for breast cancer, raising the probability of more early detections. A study conducted by Duffy et al. (2021) suggested that women who have been screened for cancer every two years and are confirmed for it after several tests had better survival rates than those who did not have prior screening. Women with breast cancer and no previous imaging tend to have their cancer advanced, increasing their chances of death. Thus, imaging is essential for screening programs as it lowers the mortality rates associated with breast cancer.
Breast Screening Program Advantages
Breast cancer imaging programs offer free services to many women worldwide, thereby enhancing their health. Prevention activities are essential in the war against cancer, which is a form of secondary care. Women no longer have to wait until breast cancer presents itself, but can be sure of their health, especially in old adulthood and old age, the period when the condition is most prevalent. With early detection, imaging programs can keep track of their health as a way to prevent any critical illnesses from taking their life at an early age (Grimm et al., 2022). When cancer is detected at an early, localized stage, the chances of successful treatment and long-term survival are significantly higher.
Moreover, the availability of screening services protects women from aggressive cancer treatment options that may be applied due to late detection. Some women have one or both of their breasts removed when they cannot be saved due to the severity of the cancer. Others might have to experience radiation therapy to kill cancerous cells.
Radiation therapy may cause damage to healthy cells near the targeted cells, potentially leading to additional complications (Grimm et al., 2022). These extreme cancer treatment interventions leave people tired, worn out, and some without an essential part of themselves that identifies them as women. Cancer screening, hence, helps prevent such outcomes for many women around the world.
Most countries with breast cancer imaging programs offer breast screening for free, which is cost-effective, especially for people unable to pay for such services. The cost of early detection and treatment is typically lower than the cost of treating advanced-stage breast cancer. The programs save people and hospitals costs associated with the treatment of breast cancer. Breast screening programs also contribute to raising awareness about breast cancer and the importance of regular screenings (French et al., 2020). This increased awareness encourages women to participate in screening programs and seek medical attention if they notice any breast abnormalities.
Finally, screening programs are essential in pinpointing women who are at higher risk for breast cancer due to factors such as family history or genetic mutations. These individuals can receive more targeted interventions and surveillance to improve early detection further (French et al., 2020). They also present researchers with rich information for studies that could improve the imaging and treatment of cancer. The future may experience more precise screening techniques following the results gathered from extending screening services to women.
Breast Screening Program Disadvantages
One of the most common shortcomings of screening is overdiagnosis, which can be obligate or non-obligate. A person can die of other causes other than an identified breast cancer condition, which indicates overdiagnosis. On the other hand, a woman can be detected to have cancer, but it might not present clinically with time because of misdiagnosis or some unknown factors (Grimm et al., 2022). In both cases, there is an act of overdiagnosis that can keep a person worried over their health, as the process identifies the illness before it presents. Some women, especially the older ones, may stop going for screening due to the overdiagnosis aspect.
Another disadvantage is the occurrence of false positives, where individuals may be subjected to unnecessary tests. For instance, a woman might be told to go for additional tests even when their mammograms show negative results for breast cancer, an aspect called false-positive recall. Other programs might ask for biopsies after recall screenings, which interfere with internal tissues when taking samples from the breast. A person might be subjected to such extreme tests for benign lesions, in the name of ensuring not to miss an active cancer case (Grimm et al., 2022). Screening programs must not subject women to unnecessary tests that might tire them for something that is not present.
Women undergo anxiety and depression following tests that might not be conclusive at times, mainly when biopsy and recall outcomes occur. Most women report having to seek coping mechanisms to deal with the pressure of not knowing whether or not they have cancer. This is a disadvantage because the higher percentage of women who go for screening turn out healthy, after undergoing the stress of waiting for their results. However, the effects are mostly short-lived, with no indication of long-term implications for healthy individuals who have been screened.
There is also a risk of exposure to radiation during screening procedures (Grimm et al., 2022). The radiation has the possibility of inducing cancer in people, creating increased cases of breast cancer. Therefore, the programs need to operate mammograms at very low radiation frequencies to prevent such occurrences.
Conclusion
Diagnostic breast cancer screening centers remain essential in promoting health among women. Many women are healthy today because of tests they undertook that saved them from a danger their bodies were unaware of before the assessment. Despite the many shortcomings, like false positives and anxiety, screening programs have undeniable benefits to people and should continue operating. However, further research is needed to identify effective ways to mitigate the disadvantages and maximize the benefits for the greater good. The future of breast cancer relies on present interventions and screening technologies, which pave the way to a better understanding of the condition.
Reference List
Duffy, S.W. et al. (2021). ‘Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: a prospective study’, Radiology, 299(3), pp.541-547.
Forrai, G., et al. (2022). ‘Use of diagnostic imaging modalities in modern screening, diagnostics and management of breast tumours 1st central-eastern European professional consensus statement on breast cancer‘, Pathology and Oncology Research, 28, p.1610382.
French, D.P., et al. (2020). ‘What are the benefits and harms of risk-stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomized comparison of BC-predict versus usual screening (NCT04359420)’, BMC cancer, 20(1), pp.1-14.
Grimm, L.J., et al. (2022). ‘Benefits and risks of mammography screening in women ages 40 to 49 years‘, Journal of Primary Care & Community Health, 13, p.21501327211058322.
Kuhl, C.K., Lehman, C. and Bedrosian, I., (2020) ‘Imaging in locoregional management of breast cancer‘, Journal of Clinical Oncology, 38(20), p.2351.
Murphy, A. (2023). ‘Breast screening programmes‘ Radiopaedia.
Nelson, H.D., et al. (2019). ‘Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force’, Jama, 322(7), pp.666-685.
Zhang, M., et al. (2023). ‘Imaging of breast cancer–beyond the basics‘, Current Problems in Cancer, 47(2), p.100967.